These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 18508689)
21. Regulation of Toll-like receptor signaling pathways in innate immune responses. Qian C; Cao X Ann N Y Acad Sci; 2013 Apr; 1283():67-74. PubMed ID: 23163321 [TBL] [Abstract][Full Text] [Related]
32. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis. Hajishengallis G; Sharma A; Russell MW; Genco RJ Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219 [TBL] [Abstract][Full Text] [Related]
33. Colchicine in ischemic heart disease: the good, the bad and the ugly. D'Amario D; Cappetta D; Cappannoli L; Princi G; Migliaro S; Diana G; Chouchane K; Borovac JA; Restivo A; Arcudi A; De Angelis A; Vergallo R; Montone RA; Galli M; Liuzzo G; Crea F Clin Res Cardiol; 2021 Oct; 110(10):1531-1542. PubMed ID: 33713178 [TBL] [Abstract][Full Text] [Related]
35. [Role of the infection and inflammation in atherosclerosis development (literature review)]. Arshinov AB; Maslova IG Angiol Sosud Khir; 2010; 17(1):35-41. PubMed ID: 21780619 [TBL] [Abstract][Full Text] [Related]
36. Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis. Gibson FC; Ukai T; Genco CA Front Biosci; 2008 Jan; 13():2041-59. PubMed ID: 17981690 [TBL] [Abstract][Full Text] [Related]
37. Inflammation and atherosclerosis: the role of TNF and TNF receptors polymorphisms in coronary artery disease. Sbarsi I; Falcone C; Boiocchi C; Campo I; Zorzetto M; De Silvestri A; Cuccia M Int J Immunopathol Pharmacol; 2007; 20(1):145-54. PubMed ID: 17346438 [TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor-mediated inflammation markers are strongly induced in heart tissue in patients with cardiac disease under both ischemic and non-ischemic conditions. Rotter Sopasakis V; Sandstedt J; Johansson M; Lundqvist A; Bergström G; Jeppsson A; Mattsson Hultén L Int J Cardiol; 2019 Oct; 293():238-247. PubMed ID: 31230935 [TBL] [Abstract][Full Text] [Related]
39. Role of Toll-like receptors in infection and immunity: clinical implications. Cristofaro P; Opal SM Drugs; 2006; 66(1):15-29. PubMed ID: 16398566 [TBL] [Abstract][Full Text] [Related]
40. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets. Cole JE; Mitra AT; Monaco C Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1619-35. PubMed ID: 21090937 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]